Carlo Patrono Selected Research

Carlo Patrono Research Topics

Disease

19	Thrombosis (Thrombus) 01/2022 - 01/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2003
11	Hemorrhage 11/2021 - 01/2004
11	Neoplasms (Cancer) 05/2021 - 02/2002
8	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 02/2002
7	Inflammation (Inflammations) 01/2019 - 10/2002
6	Essential Thrombocythemia 01/2022 - 04/2006
6	Type 2 Diabetes Mellitus (MODY) 10/2021 - 03/2004
6	Myocardial Infarction 11/2019 - 01/2004
5	COVID-19 02/2022 - 12/2020
5	Atrial Fibrillation 01/2022 - 08/2013
5	Stroke (Strokes) 10/2020 - 01/2004
5	Polycythemia Vera 01/2018 - 01/2004
4	Heart Failure 01/2022 - 03/2016
4	Acute Coronary Syndrome 05/2021 - 02/2004
3	Coronary Disease (Coronary Heart Disease) 10/2020 - 04/2005
3	Vascular Diseases (Vascular Disease) 11/2019 - 05/2009
3	Obesity 01/2017 - 10/2002
3	Pain (Aches) 10/2016 - 01/2014
2	Fibrosis (Cirrhosis) 01/2022 - 01/2019
2	Venous Thromboembolism 10/2021 - 07/2015
2	Chronic Renal Insufficiency 01/2021 - 11/2020
2	ST Elevation Myocardial Infarction 01/2021 - 05/2016
2	Diabetes Mellitus 02/2020 - 11/2019
2	Atherosclerosis 02/2020 - 06/2010
2	Ischemic Stroke 11/2019 - 02/2004
2	Neoplasm Metastasis (Metastasis) 12/2018 - 05/2016
2	Carcinogenesis 12/2018 - 10/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2016 - 07/2003
2	Adenomatous Polyps 04/2012 - 02/2002
2	Body Weight (Weight, Body) 12/2006 - 10/2002
2	Weight Loss (Weight Reduction) 12/2006 - 10/2002
2	Insulin Resistance 12/2006 - 01/2005
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2006 - 01/2004
2	Diabetic Angiopathies (Diabetic Angiopathy) 01/2005 - 07/2003
2	Vascular System Injuries 10/2004 - 10/2002
1	Rheumatoid Arthritis 01/2022
1	Pericarditis 01/2021
1	Out-of-Hospital Cardiac Arrest 11/2020
1	Adenoma (Adenomas) 10/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020

Drug/Important Bio-Agent (IBA)

36	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2022 - 01/2002
12	ThromboxanesIBA 01/2022 - 07/2003
9	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 01/2004
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020 - 02/2002
7	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2016 - 01/2003
5	11-dehydro-thromboxane B2IBA 01/2020 - 10/2002
4	Pharmaceutical PreparationsIBA 01/2018 - 09/2006
3	AnticoagulantsIBA 01/2022 - 05/2016
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021 - 09/2006
3	Dinoprostone (PGE2)FDA Link 10/2020 - 05/2016
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2019 - 02/2016
3	AntioxidantsIBA 08/2010 - 03/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2010 - 10/2002
3	ProstaglandinsIBA 02/2009 - 10/2002
3	Oxidants (Oxidizing Agents)IBA 04/2005 - 10/2002
3	8-epi-prostaglandin F2alphaIBA 01/2005 - 11/2002
2	Factor XIa (Coagulation Factor XIa)IBA 01/2022 - 01/2022
2	Arachidonic Acid (Vitamin F)IBA 01/2021 - 09/2006
2	Cyclooxygenase 1IBA 01/2019 - 02/2010
2	LipidsIBA 01/2019 - 12/2018
2	HomocysteineIBA 03/2016 - 09/2012
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2016 - 09/2012
2	antineoplaston A10 (A 10)IBA 01/2016 - 04/2012
2	C-Reactive ProteinIBA 12/2006 - 10/2002
2	CD40 Ligand (CD40L)IBA 12/2006 - 01/2006
2	Celecoxib (Celebrex)FDA Link 09/2006 - 02/2002
2	IsoprostanesIBA 04/2005 - 01/2005
2	CreatinineIBA 11/2002 - 10/2002
1	Heparin (Liquaemin)FDA LinkGeneric 02/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	abelacimabIBA 10/2021
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 10/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	LDL CholesterolIBA 01/2021
1	RivaroxabanIBA 01/2021
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020
1	Antimalarials (Antimalarial Agents)IBA 12/2020
1	remdesivirIBA 12/2020
1	dapagliflozinIBA 11/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2020
1	Colchicine FDA LinkGeneric 10/2020
1	edoxabanIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA 10/2020
1	AcidsIBA 10/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2020

Therapy/Procedure

15	Therapeutics 01/2022 - 01/2005
6	Secondary Prevention 01/2022 - 05/2009
4	Chemoprevention 10/2020 - 03/2008
2	Contraindications 04/2006 - 01/2004
1	Mediterranean Diet 01/2022
1	Percutaneous Coronary Intervention 05/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Resuscitation 11/2020